According to the Indian Council of Medical Research the vaccine developed by Indian pharmaceutical company Bharat Biotech, Covaxin has gained popularity and attention from all over the world. The vaccine is studied to be impressively safe and is currently ongoing its Phase III Clinical Trials in 22 locations across India. The results from the first two clinical trials have been very positive.
